Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Vyriad and Merck launch Phase 1 trial for innovative immuno-oncology drug combination Vyriad, a US-based biotech company, has partnered with Germany’s Merck to initiate a Phase 1 clinical trial targeting… bypharmanewsdailyJuly 18, 2018